Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological Subtype.
EpiGEICAM
breast cancer subtypes
breast neoplasm
desaturation indices
fats
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
14 Oct 2020
14 Oct 2020
Historique:
received:
26
08
2020
revised:
06
10
2020
accepted:
08
10
2020
entrez:
17
10
2020
pubmed:
18
10
2020
medline:
20
4
2021
Statut:
epublish
Résumé
This study evaluates whether serum phospholipids fatty acids (PL-FAs) and markers of their endogenous metabolism are associated with breast cancer (BC) subtypes. EpiGEICAM is a Spanish multicenter matched case-control study. A lifestyle and food frequency questionnaire was completed by 1017 BC cases and healthy women pairs. Serum PL-FA percentages were measured by gas chromatography-mass spectrometry. Conditional and multinomial logistic regression models were used to quantify the association of PL-FA tertiles with BC risk, overall and by pathological subtype (luminal, HER2+ and triple negative). Stratified analyses by body mass index and menopausal status were also performed. Serum PL-FAs were measured in 795 (78%) pairs. Women with high serum levels of stearic acid (odds ratio (OR)
Identifiants
pubmed: 33066483
pii: nu12103132
doi: 10.3390/nu12103132
pmc: PMC7602197
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
Fatty Acids
0
Phospholipids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Sociedad Española de Oncología Médica
ID : (SEOM)
Organisme : Ministerio de Economía y Competitividad
ID : IJCI-2014-20900
Organisme : Fundación Cerveza y Salud
ID : 2005
Organisme : Federación de Asociaciones de Mujeres con Cáncer de Mama
ID : (FECMA)
Organisme : Asociación Española Contra el Cancer
ID : AECC 2006 & 2016
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Nutr Cancer. 2011 Nov;63(8):1235-50
pubmed: 22043987
Public Health Nutr. 2016 Jun;19(8):1457-63
pubmed: 26434699
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Asian Pac J Cancer Prev. 2019 May 25;20(5):1321-1327
pubmed: 31127884
Clin Nutr. 2020 Mar;39(3):755-764
pubmed: 30954361
PLoS One. 2014 Feb 27;9(2):e90442
pubmed: 24587366
Int J Prev Med. 2014 Jan;5(1):6-15
pubmed: 24554986
Curr Opin Lipidol. 2011 Feb;22(1):6-10
pubmed: 20935562
Biochim Biophys Acta. 2016 Dec;1861(12 Pt A):1865-1880
pubmed: 27639967
Gynecol Oncol. 2013 Sep;130(3):609-14
pubmed: 23747837
Nutr Cancer. 2009;61(4):500-9
pubmed: 19838922
J Nutr Metab. 2017;2017:3848201
pubmed: 28781892
Am J Epidemiol. 2008 Jun 1;167(11):1312-20
pubmed: 18390841
Int J Cancer. 2016 Apr 15;138(8):1894-904
pubmed: 26595162
Am J Clin Nutr. 2007 Apr;85(4):1090-7
pubmed: 17413110
Ann Oncol. 2017 Nov 1;28(11):2836-2842
pubmed: 28950350
Adv Exp Med Biol. 2014;824:61-81
pubmed: 25038994
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Biochim Biophys Acta. 2011 Nov;1811(11):648-56
pubmed: 21787881
Nutr Hosp. 2015 Aug 01;32(2):435-77
pubmed: 26268073
PLoS One. 2015 Feb 12;10(2):e0118206
pubmed: 25675445
Biochimie. 2017 Oct;141:107-120
pubmed: 28804001
Int J Cancer. 1999 Nov 26;83(5):585-90
pubmed: 10521790
J Clin Oncol. 2018 Jul 10;36(20):2105-2122
pubmed: 29846122
Cancer Causes Control. 2016 Jun;27(6):759-73
pubmed: 27146840
Nutr J. 2013 Feb 19;12:26
pubmed: 23421854
Gynecol Oncol. 2017 Mar;144(3):577-585
pubmed: 28057355
Ann Oncol. 2019 Oct 1;30(10):1541-1557
pubmed: 31373601
Gac Sanit. 2016 Sep-Oct;30(5):379-82
pubmed: 27266514
Cancer Sci. 2013 Jun;104(6):760-4
pubmed: 23414387
Epidemiology. 1995 Jul;6(4):356-65
pubmed: 7548341
Ann Oncol. 2011 Aug;22(8):1736-47
pubmed: 21709140
Lipids. 2005 Dec;40(12):1193-200
pubmed: 16477802
J Natl Cancer Inst. 2014 Apr 09;106(5):
pubmed: 24718872
Eur J Nutr. 2019 Jun;58(4):1515-1527
pubmed: 29616321
Sci Rep. 2019 Mar 7;9(1):3904
pubmed: 30846706
BMJ. 2013 Jun 27;346:f3706
pubmed: 23814120
Oncotarget. 2017 Apr 25;8(17):29487-29500
pubmed: 28412757
Clin Transl Oncol. 2017 Jul;19(7):799-825
pubmed: 28093701
Eur J Clin Nutr. 2004 May;58(5):761-70
pubmed: 15116079
J Chromatogr A. 2020 May 24;1619:460965
pubmed: 32085913
PLoS One. 2014 Sep 15;9(9):e104083
pubmed: 25222131
J Acad Nutr Diet. 2012 Jul;112(7):1029-41, 1041.e1-15
pubmed: 22889633
Am J Epidemiol. 1985 Jul;122(1):51-65
pubmed: 4014201
Breast Cancer Res Treat. 2013 Jan;137(1):319-27
pubmed: 23208590
Curr Breast Cancer Rep. 2018 Mar;10(1):14-27
pubmed: 30662586
Exp Ther Med. 2018 Feb;15(2):1167-1176
pubmed: 29434704
Eur J Clin Nutr. 2007 Jul;61(7):925-7
pubmed: 17299500
Nutr Cancer. 2009;61(5):746-53
pubmed: 19838949
Br J Cancer. 1987 Oct;56(4):455-8
pubmed: 3689663
Int J Cancer. 2004 Sep 10;111(4):584-91
pubmed: 15239137
Curr Opin Lipidol. 2006 Feb;17(1):22-7
pubmed: 16407712
Am J Clin Nutr. 2014 Mar;99(3):431-5
pubmed: 24429537
Eur J Clin Nutr. 2000 May;54(5):367-72
pubmed: 10822282
Am J Epidemiol. 2013 Oct 15;178(8):1246-55
pubmed: 23989197
J Acad Nutr Diet. 2015 Feb;115(2):324
pubmed: 25636223
Int J Cancer. 2018 Mar 15;142(6):1116-1129
pubmed: 29071721
J Natl Cancer Inst. 2001 Jul 18;93(14):1088-95
pubmed: 11459870
Cancer Causes Control. 2009 May;20(4):497-504
pubmed: 19255861
J Clin Oncol. 2010 Jun 1;28(16):2784-95
pubmed: 20404251
Eur J Cancer Prev. 2017 Sep;26(5):385-395
pubmed: 28746163